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Abstract 
PIEZO1 is a large mechanosensitive ion channel protein. Diseases associated with PIEZO1 include 
autosomal recessive Generalised Lymphatic Dysplasia of Fotiou (GLDF) and autosomal dominant 
Dehydrated Hereditary Stomatocytosis with or without pseudohyperkalemia and/or perinatal 
oedema (DHS). The two disorders show overlapping features, fetal hydrops/perinatal oedema have 
been reported in both. Electrophysiological studies suggest opposite mechanisms of action, the 
mutations identified in GLDF patients cause a loss-of-function mechanism of disease and mutations 
in DHS patients cause gain-of-function. This raises the question, is the pathogenic disease 
mechanism behind the fetal oedema the same in the two phenotypes? In this symposium review, we 
will discuss the two conditions and highlight key questions that remain to be answered. For instance, 
the perinatal oedema often resolves soon after birth and we are still at a loss to understand why. 
Are there any mechanisms which could compensate for the faulty PIEZO1 in these patients? Are 
there physiological changes at birth that are less reliant on the function of PIEZO1? Thus, there is a 
clear need for further studies into the two disorders, in order to fully understand the role of PIEZO1 
in health and disease.  
 
Abbreviations: dbSNP, the Single Nucleotide Polymorphism Database; DHS, dehydrated hereditary 
stomatocytosis; ExAC, the Exome Aggregation Consortium; GLDF, generalised lymphatic dysplasia of 
Fotiou; MCHC, mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; 
OMIM, Online Mendelian Inheritance in Man; RBC, red blood cell. 
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Introduction 
Piezos are large mechanosensitive ion channel proteins. PIEZO1 is mainly expressed in non-sensory 
tissues while PIEZO2 is predominantly found in sensory tissues (Wu et al., 2017). Many different 
roles are being assigned to PIEZO1, e.g. contributing to the regulation of urinary osmolarity (Martins 
et al., 2016), controlling blood pressure (Wang et al., 2016), or acting as a sensor of epithelial cell 
crowding and stretching (Gudipaty et al., 2017). PIEZO1 is also expressed in developing blood vessels 
and plays a key role in blood vessel formation (Li et al., 2014; Ranade et al., 2014). OMIM lists two 
phenotypes associated with variants in the PIEZO1 gene. One is the autosomal dominant disorder, 
Dehydrated Hereditary Stomatocytosis with or without pseudohyperkalemia and/or perinatal 
oedema (DHS; OMIM 194380) caused by gain-of-function mutations. The other is autosomal 
recessive Generalised Lymphatic Dysplasia of Fotiou, with non-immune fetal hydrops (GLDF; OMIM 
616843) caused by biallelic, loss-of-function mutations. There are examples of allelic disorders in the 
literature where defects in a single gene are impIicated in different phenotypes (Zhu et al., 2014). 
For example, biallelic loss-of-function mutations in SCN9A cause autosomal recessive congenital 
insensitivity to pain (Cox et al., 2006), whereas gain-of-function, heterozygous mutations in the same 
gene cause autosomal dominant primary erythromelalgia, where there is burning pain of the lower 
limbs (Cummins et al., 2004; Yang et al., 2004). However, the paradox here is that both GLDF and 
DHS have reported cases of perinatal oedema, so it appears that both loss-of-function and gain-of-
function mutations in PIEZO1 can produce similar phenotypic features. In this symposium review, 
the two conditions caused by PIEZO1 mutations are presented, and overlapping features between 
the two phenotypes are discussed. We highlight key questions that remain to be answered to 
improve our current understanding of the role of PIEZO1 in health and disease. 
DHS: Dehydrated Hereditary Stomatocytosis – a gain-of-function phenotype 
Dehydrated Hereditary Stomatocytosis with or without pseudohyperkalemia and/or perinatal 
oedema (DHS; 194380) is an autosomal dominant haemolytic anaemia. The condition is 
characterized by mild to moderate haemolysis with varying numbers of stomatocytes on peripheral 
blood smears. There can also be an elevated MCHC (mean corpuscular haemoglobin concentration) 
and decreased osmotic fragility. Sometimes high MCV (mean corpuscular volume) and reticulocyte 
counts are reported. Probably the most sensitive test for DHS is osmotic gradient ektacytometry, 
which measures red blood cell (RBC) membrane deformability as a function of osmolality. The 
ektacytometry profile of patients with DHS is shifted to the left indicating RBC dehydration (Fig. 1). 
Another indicator of DHS is stomacytic RBCs, where cells can have the appearance of “coffee beans” 
(Fig. 2) . Other frequent clinical findings in DHS patients associated with the haemolytic anaemia are 
splenomegaly (resulting from increased red cell trapping in the spleen), cholelithiasis (due to 
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elevated bilirubin levels), infantile hepatitis, jaundice and iron overload, which can lead to 
hepatosiderosis or more widely distributed haemosiderosis. Some patients are asymptomatic, 
others have transient anaemia, which can go undetected for years. In patients with mild disease, 
stomatocytes are scarce on blood film, and often DHS patients only come to medical attention 
because of the unusual presentation of hepatosiderosis (Syfuss et al., 2006). 
Occasionally, pseudohyperkalemia is also observed in the blood samples of DHS patients. This is 
another indicator of defective cell membrane properties. It can also be a transient finding, as shown 
in a review of routine plasma potassium measurements over a 7-year period in one patient, where 
values fluctuated between high-normal and elevated (Syfuss et al., 2006). 
Some individuals with DHS also present with perinatal oedema which can vary from ascites to severe 
hydrops, including pericardial or pleural effusions and/or subcutaneous oedema (including hands 
and feet). The perinatal oedema can be so severe that it is lethal, and in utero death due to 
generalised oedema has been reported. Some are stillborn or die soon after birth. The pregnancies 
are frequently complicated by polyhydramnios. If the baby survives the pregnancy, ventilation is 
often required at birth. The hydrops sometimes resolves in utero, at other times it resolves 
spontaneously within weeks or months after birth and never recurs. Some individuals present with 
chylothoraces upon the commencement of feeding. Entezami and colleagues treated a case of intra-
uterine anaemia but they were not able to cure the oedema,  suggesting that the anaemia was not 
the cause of the oedema  (Entezami et al., 1996). It has been suggested that the ascites can be of 
hepatic origin (Rees et al., 2004). A persistent cystic hygroma, reported in one DHS case, suggests 
the oedema could be lymphatic in origin (Ami et al., 2009). The mechanism by which perinatal 
oedema and ascites develop, and then spontaneously resolve in some fetal DHS cases, has not yet 
been elucidated. No consistent dysmorphic features are associated with DHS. 
The age of onset varies widely. A family history is not essential for the diagnosis of DHS, but should 
there be one, there can be great inter-familial and intra-familial variability in expression. Because of 
the highly variable expression, DHS can be very difficult to diagnose, ranging from the absence of 
clinical symptoms to lethal perinatal oedema. For example, one report on intra-familial variation 
described how one member only had haematological symptoms, while her cousin had perinatal 
oedema but no signs of haemolytic anaemia (Grootenboer et al., 2000).  Several families have not 
been aware of their diagnosis until the occurrence of fetal oedema (Grootenboer et al., 2001). 
The condition was first reported in 1971, where Miller and collegues described a large family with 
over 50 affected members (Miller et al., 1971). Later, heterozygous missense mutations, segregating 
with the disease in DHS families (including Miller et al.), were identified in the PIEZO1 gene 
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(Zarychanski et al., 2012). This finding was corroborated by additional studies of familial and 
sporadic cases (Albuisson et al., 2013; Andolfo et al., 2013). Interestingly, upon sequencing of the 
gene in the family described by Miller et al., three of the affected siblings were found to be 
homozygous for the variant, whereas the rest of the affected family members were heterozygous 
(Zarychanski et al., 2012). It was reported that the homozygotes had severe haemolytic anaemia 
with reticulocytosis, stomatocytosis and hyperbilirubinemia, while the heterozygotes showed only 
cholelithiasis and intermittent jaundice. A number of cis-missense variants have been identified, but 
which of those contribute to the DHS phenotype is unclear (Andolfo et al., 2013).  
Human PIEZO1 is a highly polymorphic gene with many coding variants reported in the 1000 
Genomes Project database, including variants predicted as deleterious. A recent case report 
suggests that the c.7505A>G variant (dbSNP: rs34830861) can cause a DHS phenotype (Del Orbe 
Barreto et al., 2016). Although the patient showed an abnormal curve shifted to the left on 
ektacytometry, and other blood findings supported the diagnosis of DHS, the rs34830861 SNP has 
been reported in 97 heterozygous cases in ExAC. Therefore, work to determine whether this 
mutation alters PIEZO1 channel activity is warranted to confirm that it is pathogenic. Until then, this 
finding should be interpreted with caution. Electrophysiological studies have been carried out for 
several DHS-associated PIEZO1 mutations and whole-cell patch clamp demonstrated that the tested 
mutations could be defined as gain-of-function (Albuisson et al., 2013; Bae et al., 2013). The 
experiments were done in transfected HEK293 cells, and showed that mutations in PIEZO1 slowed 
the channel inactivation rate. This could explain the red blood cell (RBC) dehydration seen in PIEZO1 
mutation-positive DHS patients. Mechanistically, the slower inactivation of mutant channels causes 
an excessive calcium (Ca2+) influx into the RBC, which promotes potassium (K+) efflux through KCa3.1 
channels accompanied by osmotic efflux of water, with the subsequent cell dehydration (Cahalan et 
al., 2015). A recent paper has shown that the RBC phenotype seen in DHS patients is not just related 
to delayed channel inactivation, but a range of pathophysiological mechanisms are contributing to 
the altered channel kinetics (Glogowska et al., 2017). 
GLDF: Generalised Lymphatic Dysplasia of Fotiou – a loss-of-function phenotype 
Autosomal recessive Generalised Lymphatic Dysplasia of Fotiou (GLDF; OMIM 616843) is 
characterised by a widespread lymphoedema that can affect all segments of the body. Like DHS, 
GLDF has a high incidence of non-immune fetal hydrops, i.e. presenting with persistent bilateral 
pleural effusions, ascites and subcutaneous oedema, with either fetal death or a complete resolution 
of the hydrops postnatally. The pregnancies are frequently complicated by polyhydramnios. The 
babies are often hydropic at birth with generalised oedema and pleural effusions requiring 
ventilation for several weeks. After introduction of milk feeds, the pleural effusions become chylous.  
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Sometimes lymphoedema of the peripheries recurs in early childhood. This is mainly lower limb 
lymphoedema, but can also involve the hands, arms and face (which may be intermittent). Genital 
oedema, which may be intermittent, is frequent in males, sometimes with thickened scrotum,  
oedema of the foreskin, and hydroceles. Many patients have multiple episodes of cellulitis in their 
legs, and several of the patients have also had intermittent, severe facial swelling due to recurrent 
facial cellulitis. The facial cellulitis is a striking feature, and is rarely seen in other forms of primary 
lymphoedema. Four cases with severe, recurrent facial cellulitis and significant morbidity have been 
reported (Fotiou et al., 2015). There was high pyrexia and respiratory distress that led to admission 
to intensive care with ventilation. In addition to facial swelling, some of the patients had mild 
dysmorphic features (cupped simple ears, mild telecanthus due to epicanthic folds, and 
micrognathia). Some patients were also reported to have varicose veins, papillomatosis, verrucas 
and warts.  Many of the affected children had systemic involvement with chylothoraces and/or 
pericardial effusions – but intestinal lymphangiectasia is rare (personal observation). 
It was noted that GLDF patients and unaffected carriers were also found to have mild changes 
(occasional stomatocytes and/or spherocytes) on their blood film, but with no history of haemolytic 
anaemia. It is questionable whether observations on the blood film are comparable to that of the 
DHS patients, as more work is needed in this area. 
Through whole exome sequencing, Fotiou and colleagues identified biallelic, homozygous and 
compound heterozygous mutations in the PIEZO1 gene (Fotiou et al., 2015). The mutations 
segregated with the phenotype in the families. An independent study by Lukacs and colleagues 
confirmed this finding (Lukacs et al., 2015). A mix of missense, stop-gain (nonsense), frameshift and 
splice site variants have been identified. Sanger sequencing of cDNA from carriers of a splice site 
mutation showed that intron 13 was not spliced out in the mutant protein. None of the variants, 
except for 2 found in cis, were found in the dbSNP, or 1000 Genomes Project databases or in 900 in-
house control samples (Fotiou et al., 2015). 
Western blot analysis of RBCs from GLDF patients showed a complete absence or reduction of 
PIEZO1 protein expression compared to a healthy control (Fotiou et al., 2015). Analysis of RBCs from 
a patient with biallelic mutations in PIEZO1 showed decreased PIEZO1 function (Lukacs et al., 2015). 
This was mainly due to a reduced abundance of PIEZO1 channels in the RBC plasma membrane. The 
absence of symptoms in the parents carrying just one variant each, argue against a dominant 
negative effect of the variants. Where the DHS-associated PIEZO1 mutations have been shown to 
lead to dehydration of RBCs due to excessive calcium influx, the GLDF associated PIEZO1 mutations 
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give rise to decreased PIEZO1 function with no calcium influx. As a consequence, reduced influx of 
calcium may cause fluid retention in the RBCs leading to “hyper-hydration” (Cahalan et al., 2015). 
Piezo1 is expressed in embryonic endothelial cells and Piezo1 deficiency causes the disruption of 
vascular development in the mouse embryo. Loss of PIEZO1 results in reduced mechanosensitivity of 
the endothelial cells in terms of alignment and organization in the direction of flow in response to 
shear stress. Mechanistically, Piezo1 channel activity is stimulated by shear stress leading to calcium 
(Ca2+) entry in the endothelial cell, increased calpain activity, and modification of the actin 
cytoskeleton and the focal adhesions required for cell reorganization (Li et al., 2014; Ranade et al., 
2014). Mechanotransduction is also a critical regulator of lymphatic vascular development, and 
shear stress triggers signalling pathways that promote lymphatic vessel maturation and lymphatic 
valve formation (Sabine et al., 2012; Cha et al., 2016).  The loss of PIEZO1 function in GLDF patients 
and consequent defects in mechanical stimulation and downstream signalling pathways, could 
disrupt embryonic lymphatic vascular development. This could result in the progression of hydrops 
or childhood onset peripheral oedema. 
Discussion  
In summary, we have presented two conditions caused by mutations in the PIEZO1 gene, autosomal 
recessive GLDF caused by loss of function, and autosomal dominant DHS where the disease is a gain 
of function. In disorders with phenotypic heterogeneity, where different mutations in the same gene 
give rise to different phenotypes, mutations usually have distinct effects on biochemical and cellular 
activities. Furthermore, disease specific mutations tend to cluster in key regions. For example, 
missense mutations in Dynamin2 (DNM2) have been described in association with four different 
phenotypes, depending on which domain of the DNM2 gene the mutation is located in (Brown et al., 
2017). PIEZO1 missense variants are common in both GLDF and DHS, but a one domain – one 
disease pattern is not clear. The missense variants show a wide distribution across the gene, and the 
GLDF missense variants are interspersed among the DHS missense variants (Fotiou et al., 2015). 
Therefore, the clinical phenotype may depend on the nature of the conformational change produced 
by a disease specific mutation at the individual genomic position in PIEZO1. Interestingly, 
centronuclear myopathy (CNM), one of the DNM2-associated phenotypes, is usually caused by 
mutations in the PH domain, but a few missense mutations have been identified interspersed with 
Charcot-Marie-Tooth (CMT) neuropathy-associated missense mutations in the middle domain of the 
DNM2 gene. Chin and colleagues demonstrated that the mutations had different effects on protein 
function and that CMT was caused by loss-of-function mechanisms and CNM was caused by gain-of-
function mechanisms (Chin et al., 2015).  
8 
 
The mutations in PIEZO1 have also been shown to have distinct effects. The gain-of-function 
mutations were reported to increase calcium influx into RBCs leading to their dehydration. The loss-
of-function mutations were reported to yield no calcium influx, which may lead to the over-
hydration of RBCs. According to the literature, ektacytometry is the most effective method for 
diagnosing DHS, rather than direct observation of blood films alone. None of the patients in Fotiou 
et al. underwent ektacytometry, and it would be interesting to study this further, to see if the 
ektacytomery curve in the GLDF patients show a shift to the right, in contrast to the shift to the left 
observed in DHS patients. Could ektacytometry consequently be an equally suitable method for the 
diagnosis of GLDF? 
Although caused by different disease mechanisms, the two disorders at first sight show some 
overlapping features. For example, fetal hydrops has been reported for both disorders (Fig. 2). Fetal 
hydrops is not the cause of disease, but rather an outcome of an underlying developmental problem 
(Bellini et al., 2015). Therefore, we need to understand better the fetal hydrops in both DHS and 
GLDF cases, to determine whether they have the same cause. The GLDF hydrops seems most likely 
to be lymphatic in origin, but is this also true in DHS? Or could it be hepatic in origin as previously 
suggested (Rees et al., 2004)? It is also unclear why the hydrops resolves at birth. Are there changes 
that occur then which could compensate for the defective function of PIEZO1? 
Interestingly, in some GLDF patients, the fetal hydrops resolved soon after birth, but persistent 
peripheral oedema appeared later in childhood. This does not seem to be the case in DHS patients, 
at least this has not been reported. If, as suggested above, the hydrops is due to different disease 
mechanisms, the underlying fault is then not necessarily producing the same effect later in life. This 
could explain the development of peripheral oedema in one disorder and not the other. It is not 
clear whether the DHS patients have been examined for peripheral oedema later in life. Particularly 
those who presented with hydrops (if they survived). Perhaps the fetuses with perinatal oedema 
associated with the DHS phenotype, have a second, but as yet unidentified, hit or variant in PIEZO1 
or a modifying gene. 
The fact that the fetal hydrops in both conditions are able to fully resolve in the few weeks after 
birth, suggests a physiological change at birth that is having a major effect on the oedema. If this 
could be understood, the potential for treatment of this, and other lymphatic related hydrops, is 
tangible. There is clearly a need for more work to be carried out, in order to fully understand the role 
of PIEZO1 in the two disorders presented here.  
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Abstract figure legend:  
Two human phenotypes, DHS and GLDF, with some overlapping clinical features are caused by 
mutations in the PIEZO1 gene. Recombinant PIEZO1 channels with GLDF-associated loss-of-function 
mutations display a strongly diminished response to stimulus (red squares in upper panel) compared 
to wildtype (black squares). In DHS patients, the slower inactivation of mutant PIEZO1 channels leads 
to an excess of calcium influx into the cell and an increased potassium efflux from the cell. The ability 
of the ATP driven Na+-K+ pump to maintain osmotic balance is outweighed by the gain of function in 
the PIEZO1 channel, causing loos of cell water and decrease in volume. This change in cell membrane 
permeability causes the red blood cell to dehydrate. PIEZO1 channels play a crucial role in 
cardiovascular development and adult cardiovascular function, and are activated by fluid shear 
stress. The ability of PIEZO1 to sense shear stress suggests a role connecting mechanotransduction 
and lymphovascular development and function. 
 
 
Figure 1. Ektacytometry curves in DHS.  This idealised graph shows RBC membrane deformability 
(using the elongation index) as a function of osmolality. The ektacytometry osmotic deformability 
profile of a DHS patient (broken red line) is shifted to the left of the healthy control (solid black line) 
indicating high osmotic resistance and RBC dehydration.  
 
 
Figure 2. Contrasting DHS and GLDF. (A) Patients with DHS can present with fetal hydrops. They are 
characterised by mouth-shaped (stomatocytic) red blood cells. The red blood cell dehydration seen 
in DHS patients is due to altered permeability of the RBC membrane which causes a loss of cation 
content due to the gain-of-function (GOF) mutations in PIEZO1. (B) Patients with GLDF can also 
present with fetal hydrops. In contrast to DHS, the GLDF patients often develop childhood onset of 
peripheral oedema, indicating that in GLDF the hydrops could be due to an underlying lymphatic 
problem. Is the fetal hydrops due to the same underlying disease mechanism in the two conditions?  
Do all GLDF patients present with stomatocytes or spherocytes on their blood films? Not enough 
cases have been investigated to make a firm conclusion. Will the loss-of-function (LOF) mutations in 
GLDF patients lead to overhydrated red blood cells? Many questions remain unanswered, thus there 
is a clear need for more studies into the functional role of PIEZO1.  
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